Annual Short Term Debt
$1.37 M
+$174.10 K+14.53%
December 31, 2024
Summary
- As of March 10, 2025, MLTX annual short term debt is $1.37 million, with the most recent change of +$174.10 thousand (+14.53%) on December 31, 2024.
- During the last 3 years, MLTX annual short term debt has fallen by -$13.63 million (-90.85%).
- MLTX annual short term debt is now -90.85% below its all-time high of $15.00 million, reached on December 31, 2021.
Performance
MLTX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$1.37 M
-$380.50 K-21.71%
December 31, 2024
Summary
- As of March 10, 2025, MLTX quarterly short term debt is $1.37 million, with the most recent change of -$380.50 thousand (-21.71%) on December 31, 2024.
- Over the past year, MLTX quarterly short term debt has dropped by -$380.50 thousand (-21.71%).
- MLTX quarterly short term debt is now -90.85% below its all-time high of $15.00 million, reached on December 31, 2021.
Performance
MLTX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
MLTX Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.5% | -21.7% |
| 3 y3 years | -90.8% | +784.0% |
| 5 y5 years | -90.8% | +784.0% |
MLTX Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -90.8% | +793.2% | -90.8% | +793.2% |
| 5 y | 5-year | -90.8% | +793.2% | -90.8% | +793.2% |
| alltime | all time | -90.8% | +793.2% | -90.8% | +793.2% |
MoonLake Immunotherapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.37 M(+14.5%) | $1.37 M(-21.7%) |
| Sep 2024 | - | $1.75 M(+32.6%) |
| Jun 2024 | - | $1.32 M(+1.3%) |
| Mar 2024 | - | $1.30 M(+8.9%) |
| Dec 2023 | $1.20 M | $1.20 M(+666.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $156.30 K(-1.2%) |
| Jun 2023 | - | $158.20 K(+1.9%) |
| Mar 2023 | - | $155.20 K(+1.0%) |
| Dec 2022 | $153.60 K(-99.0%) | $153.60 K(-99.0%) |
| Dec 2021 | $15.00 M | $15.00 M |
FAQ
- What is MoonLake Immunotherapeutics annual short term debt?
- What is the all time high annual short term debt for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual short term debt year-on-year change?
- What is MoonLake Immunotherapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly short term debt year-on-year change?
What is MoonLake Immunotherapeutics annual short term debt?
The current annual short term debt of MLTX is $1.37 M
What is the all time high annual short term debt for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual short term debt is $15.00 M
What is MoonLake Immunotherapeutics annual short term debt year-on-year change?
Over the past year, MLTX annual short term debt has changed by +$174.10 K (+14.53%)
What is MoonLake Immunotherapeutics quarterly short term debt?
The current quarterly short term debt of MLTX is $1.37 M
What is the all time high quarterly short term debt for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly short term debt is $15.00 M
What is MoonLake Immunotherapeutics quarterly short term debt year-on-year change?
Over the past year, MLTX quarterly short term debt has changed by -$380.50 K (-21.71%)